These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6643342)

  • 21. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide.
    Zaleznik DF; Zhang ZL; Onderdonk AB; Kasper DL
    J Infect Dis; 1986 Jul; 154(1):40-6. PubMed ID: 3711690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis.
    Reid JH; Patrick S
    J Med Microbiol; 1984 Jun; 17(3):247-57. PubMed ID: 6726784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of clindamycin on stimulation of cell adhesion molecules by endotoxins and enterotoxin of Bacteroides fragilis strains].
    Meisel-Mikołajczyk F; Rokosz A; Kot K; Zawidzka E; Malchar C; Nowaczyk M; Górski A
    Med Dosw Mikrobiol; 2001; 53(2):151-60. PubMed ID: 11757424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus.
    Veringa EM; Verhoef J
    Chemotherapy; 1987; 33(4):243-9. PubMed ID: 3608624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of antibiotic resistant strains of Bacteroides fragilis.
    Scher KS
    Surg Gynecol Obstet; 1988 Sep; 167(3):175-9. PubMed ID: 3413646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of subinhibitory concentrations of clindamycin on the morphological, biochemical and genetic characteristics of Bacteroides fragilis.
    Silvestro EM; Nakano V; Arana-Chavez VE; Marques MV; Avila-Campos MJ
    FEMS Microbiol Lett; 2006 Apr; 257(2):189-94. PubMed ID: 16553852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyruvate dehydrogenase activity and metronidazole susceptibility in Bacteroides fragilis.
    Tabaqchali S; Pantosti A; Oldfield S
    J Antimicrob Chemother; 1983 May; 11(5):393-400. PubMed ID: 6874627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of suprainhibitory (supra-MIC) concentration of clindamycin on endotoxin release from Bacteroides fragilis].
    Rokosz A; Meisel-Mikołajczyk F
    Med Dosw Mikrobiol; 1999; 51(1-2):143-9. PubMed ID: 10865440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of subminimal inhibitory concentrations of clindamycin and Escherichia coli: effects on adhesion and polymorphonuclear leukocyte function.
    Bassaris HP; Lianou PE; Papavassiliou JT
    J Antimicrob Chemother; 1984 Apr; 13(4):361-7. PubMed ID: 6373717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial killing in vitro by abscess-derived neutrophils.
    Finlay-Jones JJ; Hart PH; Spencer LK; Nulsen MF; Kenny PA; McDonald PJ
    J Med Microbiol; 1991 Feb; 34(2):73-81. PubMed ID: 1990143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vitro activity of ciprofloxacin combined with flomoxef against Bacteroides fragilis, compared with that of ciprofloxacin combined with clindamycin.
    Kato K; Iwai S; Sato T; Harada T; Nakagawa Y; Iwanaga H; Ito Y; Takayama T
    J Infect Chemother; 2002 Jun; 8(2):190-3. PubMed ID: 12111577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteroides fragilis group: trends in resistance.
    Fille M; Mango M; Lechner M; Schaumann R
    Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
    Thadepalli H; Chuah SK; Gollapudi S
    Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clindamycin resistance transfer in Bacteroides fragilis.
    Teng LJ; Liaw SJ; Luh KT; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Nov; 27(4):186-95. PubMed ID: 9747348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic analysis of clindamycin resistance in Bacteroides species.
    Guiney DG; Hasegawa P; Stalker D; Davis CE
    J Infect Dis; 1983 Mar; 147(3):551-8. PubMed ID: 6833799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bactericidal activity of tinidazole. An in vitro comparison of the effects of tinidazole and metronidazole against Bacteroides fragilis and other Anaerobic bacteria.
    Jokipii AM; Jokipii L
    Chemotherapy; 1977; 23(1):25-31. PubMed ID: 318974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aerobic and anaerobic bacterial interactions in the development of anaerobic bacterial pneumonia.
    Goto J
    Kansenshogaku Zasshi; 1992 Dec; 66(12):1660-9. PubMed ID: 1294672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
    Schaumann R; Petzold S; Fille M; Rodloff AC
    Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
    Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of phagocytosis in vitro by obligate anaerobes.
    Ingham HR; Sisson PR; Tharagonnet D; Selkon JB; Codd AA
    Lancet; 1977 Dec; 2(8051):1252-4. PubMed ID: 73952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.